e6vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January, 2011
Commission File Number 1-14840
AMDOCS LIMITED
Suite 5, Tower Hill House Le Bordage
St. Peter Port, Island of Guernsey, GY1 3QT
Amdocs, Inc.
1390 Timberlake Manor Parkway, Chesterfield, Missouri 63017
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
FORM 20-F   x                    FORM 40-F   o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):   o
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):   o
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to rule 12g3-2(b) under the Securities Exchange Act of 1934.
YES   o                    NO   x
 
 

 


 

     On January 25, 2011, Amdocs Limited (“Amdocs”) issued a press release announcing financial results for the quarter ended December 31, 2010. A copy of the press release is furnished as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K.
     The information in this Form 6-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

 


 

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
  AMDOCS LIMITED
 
 
  /s/ Thomas G. O’Brien    
  Thomas G. O’Brien   
  Treasurer and Secretary Authorized U.S. Representative   
 
Date: January 25, 2011

 


 

EXHIBIT INDEX
         
EXHIBIT NO.   DESCRIPTION
  99.1    
Amdocs Limited Press Release dated January 25, 2011.

 

exv99w1
Exhibit 99.1
(AMDOCS LOGO)
Amdocs Limited Reports Quarterly Revenue of $775 Million, Up 6.9% YoY
Expects 4-6% Revenue Growth in Fiscal 2011 and Improving Profitability
During the Fiscal Year
Key highlights:
    First fiscal quarter revenue of $775 million, compared to the $760-$780 million guidance range. Similar to what was factored into the guidance, foreign currency movements positively impacted revenue by approximately $6 million sequentially relative to the fourth fiscal quarter of 2010
 
    First fiscal quarter non-GAAP operating income of $120 million; non-GAAP operating margin of 15.5%; GAAP operating income of $88 million
 
    First fiscal quarter diluted non-GAAP EPS of $0.52, compared to the $0.49-$0.58 guidance range, excluding amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expense, net of related tax effects
 
    Diluted GAAP EPS of $0.38 for the first fiscal quarter, compared to the $0.34-$0.45 guidance range
 
    Free cash flow of $127 million for the first fiscal quarter
 
    Twelve-month backlog of $2.56 billion at the end of the first fiscal quarter, up $35 million from the end of the fourth fiscal quarter of 2010
 
    Second quarter fiscal 2011 guidance: Expected revenue of approximately $775-$790 million and diluted non-GAAP EPS of $0.53-$0.60, excluding acquisition-related costs and approximately $0.03-$0.04 per share of equity-based compensation expense, net of related tax effects. Diluted GAAP EPS is expected to be approximately $0.43-$0.51
 
    Expected revenue growth of 4-6% in fiscal 2011 as compared to fiscal 2010
 
    Repurchased $113 million of ordinary shares during the first fiscal quarter
ST. LOUIS — January 25, 2011 — Amdocs Limited (NYSE: DOX) today reported that for its first fiscal quarter ended December 31, 2010, revenue was $775.2 million, up 1.7% sequentially from the fourth fiscal quarter of 2010 and up 6.9% as compared to last year’s first fiscal quarter. Net income on a non-GAAP basis was $99.8 million, or $0.52 per diluted share,

 


 

compared to non-GAAP net income of $113.1 million, or $0.55 per diluted share, in the first quarter of fiscal 2010. Non-GAAP net income excludes amortization of purchased intangible assets and other acquisition related costs and equity-based compensation expenses of $26.4 million, net of related tax effects, in the first quarter of fiscal 2011 and excludes such amortization and equity-based compensation expenses of $24.8 million, net of related tax effects, in the first quarter of fiscal 2010. The Company’s GAAP net income for the first quarter of fiscal 2011 was $73.4 million, or $0.38 per diluted share, compared to GAAP net income of $88.4 million, or $0.43 per diluted share, in the prior year’s first quarter.
“Our performance in the first fiscal quarter of 2011 reflects continued revenue growth for Amdocs as a result of healthy demand trends. Additionally, consistent with our guidance, the results reflect a decline in the operating margin due to the effects of several of the current investment initiatives we had cited last quarter, including the one-time impact of winning the strategic emerging markets contract. Furthermore, we made progress over the course of the first quarter with some of our key near-term challenges while sharpening our focus on the long-term growth initiatives of the company,” said Eli Gelman, chief executive officer of Amdocs Management Limited.
Gelman continued, “Specific to the discussion of near-term profitability, we have important updates on the progress we made against several initiatives and issues that we shared last quarter, including:
    First, we are pleased to report that in the first fiscal quarter we won the agreement with the emerging markets customer that we referenced in our November 3, 2010 earnings announcement. While this agreement resulted in a non-recurring upfront expense, it significantly expands a strategic relationship with a key global service provider and, we believe, opens an even larger opportunity for long-term growth in the region in which the emerging markets customer operates.
 
    Second, we successfully re-scoped our contract with Clearwire to address the changes in the customer’s strategic direction. Amdocs and Clearwire continue to maintain a strong, long-term managed services relationship.
 
    Third, we have begun to realize early benefits in our employee productivity as a result of the focused investments we made in our knowledge base during the first quarter. Given the importance of employee knowledge to our long-term success, we expect to continue making these investments throughout the remainder of 2011.

 


 

    Lastly, we made important progress with key customer implementations during the first quarter, including in the cable industry; however, we are still engaged in some of the industry’s most complex projects which may require continued investment in the near-term.”
Gelman concluded, “After my first quarter as CEO, I am even more excited about the opportunities in front of Amdocs. Furthermore, I have greater confidence that we have both identified and are appropriately addressing our near-term challenges while focusing the company on the growth potential ahead of us. Looking forward, we now expect revenue to grow in the range of 4-6% in fiscal 2011 as compared to fiscal 2010. In addition, we expect profitability to improve during the fiscal year as we begin to realize the benefits of our internal and customer-focused investments.”
Financial Discussion of First Fiscal Quarter Results
Free cash flow was $127 million for the quarter, comprised of cash flow from operations of $162 million less approximately $35 million in net capital expenditures and other.
Twelve-month backlog, which includes anticipated revenue related to contracts, estimated revenue from managed services contracts, letters of intent, maintenance and estimated on-going support activities, was $2.56 billion at the end of the first quarter of fiscal 2011.
Financial Outlook
Amdocs expects that revenue for the second quarter of fiscal 2011 will be approximately $775-$790 million. Diluted earnings per share on a non-GAAP basis for the second quarter are expected to be $0.53-$0.60, excluding acquisition-related costs and approximately $0.03-$0.04 per share of equity-based compensation expense, net of related tax effects. Amdocs estimates GAAP diluted earnings per share for the second quarter will be $0.43-$0.51.
Conference Call Details
Amdocs will host a conference call on January 25, 2011 at 5:00 p.m. Eastern Time to discuss the Company’s first quarter results. The call will be carried live on the Internet via the Amdocs website, www.amdocs.com.
Non-GAAP Financial Measures
This release includes non-GAAP diluted earnings per share and other non-GAAP financial

 


 

measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income. These non-GAAP measures exclude the following items:
    amortization of purchased intangible assets and other acquisition related costs;
 
    equity-based compensation expense; and
 
    tax effects related to the above.
These non-GAAP financial measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles. Amdocs believes that non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with Amdocs’ results of operations as determined in accordance with GAAP and that these measures should only be used to evaluate Amdocs’ results of operations in conjunction with the corresponding GAAP measures.
Amdocs believes that the presentation of non-GAAP diluted earnings per share and other financial measures, including free cash flow, non-GAAP cost of service, non-GAAP research and development, non-GAAP selling, general and administrative, non-GAAP operating income, non-GAAP operating margin, non-GAAP income taxes and non-GAAP net income, when shown in conjunction with the corresponding GAAP measures, provides useful information to investors and management regarding financial and business trends relating to its financial condition and results of operations, as well as the net amount of cash generated by its business operations after taking into account capital spending required to maintain or expand the business.
For its internal budgeting process and in monitoring the results of the business, Amdocs’ management uses financial statements that do not include amortization of purchased intangible assets and other acquisition related costs, equity-based compensation expense and related tax effects. Amdocs’ management also uses the foregoing non-GAAP financial measures, in addition to the corresponding GAAP measures, in reviewing the financial results of Amdocs. In addition, Amdocs believes that significant groups of investors exclude these non-cash expenses in reviewing its results and those of its competitors, because the amounts

 


 

of the expenses between companies can vary greatly depending on the assumptions used by an individual company in determining the amounts of the expenses.
Amdocs further believes that, where the adjustments used in calculating non-GAAP diluted earnings per share are based on specific, identified amounts that impact different line items in the Consolidated Statements of Income (including cost of service, research and development, selling, general and administrative, operating income, income taxes and net income), it is useful to investors to understand how these specific line items in the Consolidated Statements of Income are affected by these adjustments.
Please refer to the Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP tables below.
About Amdocs
Amdocs is the market leader in customer experience systems innovation. The company combines business and operational support systems, service delivery platforms, proven services, and deep industry expertise to enable service providers and their customers to do more in the connected world. Amdocs’ offerings help service providers explore new business models, differentiate through personalized customer experiences, and streamline operations. A global company with revenue of approximately $3.0 billion in fiscal 2010, Amdocs has over 19,000 employees and serves customers in more than 60 countries worldwide. For more information, visit Amdocs at www.amdocs.com.
This press release includes information that constitutes forward-looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995, including statements about Amdocs growth and business results in future quarters. Although we believe the expectations reflected in such forward-looking statements are based upon reasonable assumptions, we can give no assurance that our expectations will be obtained or that any deviations will not be material. Such statements involve risks and uncertainties that may cause future results to differ from those anticipated. These risks include, but are not limited to, the effects of general economic conditions, Amdocs ability to grow in the business markets that it serves, Amdocs ability to successfully integrate acquired businesses, adverse effects of market competition, rapid technological shifts that may render the Company’s products and services obsolete, potential loss of a major customer, our ability to develop long-term relationships with our customers, and risks associated with operating businesses in the

 


 

international market. Amdocs may elect to update these forward-looking statements at some point in the future; however, the Company specifically disclaims any obligation to do so. These and other risks are discussed at greater length in the Company’s filings with the Securities and Exchange Commission, including in our Annual Report on Form 20-F for the fiscal year ended September 30, 2010 filed on December 7, 2010.
Contact:
Elizabeth W. Grausam
Vice President of Investor Relations
Amdocs
314-212-8328
E-mail: dox_info@amdocs.com
 

 


 

AMDOCS LIMITED
Consolidated Statements of Income
(in thousands, except per share data)
                 
    Three months ended  
    December 31,  
    2010     2009  
Revenue:
               
License
  $ 29,906     $ 24,150  
Service
    745,275       700,661  
 
           
 
    775,181       724,811  
 
               
Operating expenses:
               
Cost of license
    700       442  
Cost of service
    508,138       462,215  
Research and development
    54,992       50,106  
Selling, general and administrative
    104,357       91,580  
Amortization of purchased intangible assets and other
    19,410       21,319  
 
           
 
    687,597       625,662  
 
           
Operating income
    87,584       99,149  
 
               
Interest and other expense, net
    3,117       715  
 
           
Income before income taxes
    84,467       98,434  
 
               
Income taxes
    11,076       10,081  
 
           
Net income
  $ 73,391     $ 88,353  
 
           
Basic earnings per share
  $ 0.38     $ 0.43  
 
           
Diluted earnings per share
  $ 0.38     $ 0.43  
 
           
Basic weighted average number of shares outstanding
    191,599       205,430  
 
           
Diluted weighted average number of shares outstanding
    192,969       206,656  
 
           

 


 

AMDOCS LIMITED
Selected Financial Metrics
(in thousands, except per share data)
                 
    Three months ended
    December 31,
    2010   2009
Revenue
  $ 775,181     $ 724,811  
 
               
Non-GAAP operating income
    120,268       131,321  
 
               
Non-GAAP net income
    99,769       113,127  
 
               
Non-GAAP diluted earnings per share
  $ 0.52     $ 0.55  
 
               
Diluted weighted average number of shares outstanding
    192,969       206,656  

 


 

AMDOCS LIMITED
Reconciliation of Selected Financial Metrics from GAAP to Non-GAAP
(in thousands)
                                         
    Three months ended
    December 31, 2010
            Reconciliation items    
            Amortization of            
            purchased   Equity based        
            intangible assets   Compensation        
    GAAP   and other   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 700     $     $     $     $ 700  
Cost of service
    508,138             (4,484 )           503,654  
Research and development
    54,992             (849 )           54,143  
Selling, general and administrative
    104,357             (7,941 )           96,416  
Amortization of purchased intangible assets and other
    19,410       (19,410 )                  
     
Total operating expenses
    687,597       (19,410 )     (13,274 )           654,913  
     
 
                                       
     
Operating income
    87,584       19,410       13,274             120,268  
     
 
                                       
     
Income taxes
    11,076                   6,306       17,382  
     
 
                                       
     
Net income
  $ 73,391     $ 19,410     $ 13,274     $ (6,306 )   $ 99,769  
     
                                         
    Three months ended
    December 31, 2009
            Reconciliation items        
            Amortization of            
            purchased   Equity based        
            intangible assets   compensation        
    GAAP   and other   expense   Tax effect   Non-GAAP
     
Operating expenses:
                                       
Cost of license
  $ 442     $     $     $     $ 442  
Cost of service
    462,215             (4,785 )           457,430  
Research and development
    50,106             (1,133 )           48,973  
Selling, general and administrative
    91,580             (4,935 )           86,645  
Amortization of purchased intangible assets and other
    21,319       (21,319 )                  
     
Total operating expenses
    625,662       (21,319 )     (10,853 )           593,490  
     
 
                                       
     
Operating income
    99,149       21,319       10,853             131,321  
     
 
                                       
     
Income taxes
    10,081                   7,398       17,479  
     
 
                                       
     
Net income
  $ 88,353     $ 21,319     $ 10,853     $ (7,398 )   $ 113,127  
     

 


 

AMDOCS LIMITED
Condensed Consolidated Balance Sheets
(in thousands)
                 
    As of  
    December 31,     September 30,  
    2010     2010  
ASSETS
               
 
               
Current assets
               
Cash, cash equivalents and short-term interest-bearing investments
  $ 1,251,639     $ 1,433,299  
Accounts receivable, net, including unbilled of $65,634 and $62,246, respectively
    547,867       580,000  
Deferred income taxes and taxes receivable
    137,879       126,083  
Prepaid expenses and other current assets
    156,720       112,417  
 
           
Total current assets
    2,094,105       2,251,799  
 
               
Equipment and leasehold improvements, net
    250,902       258,273  
Goodwill and other intangible assets, net
    1,836,722       1,856,178  
Other noncurrent assets
    465,614       454,354  
 
           
Total assets
  $ 4,647,343     $ 4,820,604  
 
           
 
               
LIABILITIES AND SHAREHOLDERS’ EQUITY
               
 
               
Current Liabilities
               
Accounts payable, accruals and other
  $ 614,148     $ 621,549  
Short-term financing arrangements
          200,000  
Deferred revenue
    216,258       184,481  
Deferred income taxes and taxes payable
    16,457       18,117  
 
           
Total current liabilities
    846,863       1,024,147  
Other noncurrent liabilities
    581,508       567,077  
Shareholders’ equity
    3,218,972       3,229,380  
 
           
Total liabilities and shareholders’ equity
  $ 4,647,343     $ 4,820,604  
 
           

 


 

AMDOCS LIMITED
Consolidated Statements of Cash Flows
(in thousands)
                 
    Three months ended December 31,  
    2010     2009  
Cash Flow from Operating Activities:
               
Net income
  $ 73,391     $ 88,353  
Reconciliation of net income to net cash provided by operating activities:
               
Depreciation and amortization
    49,153       50,050  
Equity-based compensation expense
    13,274       10,853  
Deferred income taxes
    6,903       (8,501 )
Excess tax benefit from equity-based compensation
    (24 )     (17 )
Loss (gain) from short-term interest-bearing investments
    832       (329 )
Net changes in operating assets and liabilities, net of amounts acquired:
               
Accounts receivable
    34,330       (22,161 )
Prepaid expenses and other current assets
    (40,891 )     6,159  
Other noncurrent assets
    (26,751 )     (14,409 )
Accounts payable, accrued expenses and accrued personnel
    5,462       28,258  
Deferred revenue
    39,015       47,599  
Income taxes payable
    (2,515 )     4,534  
Other noncurrent liabilities
    10,122       3,118  
 
           
Net cash provided by operating activities
    162,301       193,507  
 
           
 
               
Cash Flow from Investing Activities:
               
Payments for purchase of equipment and leasehold improvements, net
    (35,340 )     (23,589 )
Proceeds from sale of short-term interest-bearing investments
    124,797       278,183  
Purchase of short-term interest-bearing investments
    (88,605 )     (348,662 )
Net cash paid for acquisitions
          (56,454 )
Other
    (7,672 )      
 
           
Net cash used in investing activities
    (6,820 )     (150,522 )
 
           
 
               
Cash Flow from Financing Activities:
               
Payments under financing arrangements
    (200,000 )      
Repurchase of shares
    (113,431 )      
Proceeds from employee stock options exercised
    13,845       5,141  
Payments under capital lease, short-term financing arrangements and other
    (228 )     (104 )
 
           
Net cash (used in) provided by financing activities
    (299,814 )     5,037  
 
           
 
               
Net (decrease) increase in cash and cash equivalents
    (144,333 )     48,022  
Cash and cash equivalents at beginning of period
    1,036,195       728,762  
 
           
Cash and cash equivalents at end of period
  $ 891,862     $ 776,784  
 
           

 


 

AMDOCS LIMITED
Supplementary Information
(in millions)
                                         
    Three months ended  
    December 31,     September 30,     June 30,     March 31,     December 31,  
    2010     2010     2010     2010     2009  
North America
  $ 564.6     $ 569.7     $ 572.3     $ 572.4     $ 547.6  
Europe
    98.4       91.0       80.6       92.1       89.5  
Rest of World
    112.2       101.5       100.3       79.5       87.7  
 
                             
Total Revenue
  $ 775.2     $ 762.2     $ 753.2     $ 744.0     $ 724.8  
 
                             
                                         
    Three months ended  
    December 31,     September 30,     June 30,     March 31,     December 31,  
    2010     2010     2010     2010     2009  
Customer Experience Systems
  $ 725.4     $ 714.9     $ 693.0     $ 689.0     $ 678.4  
Directory
    49.8       47.3       60.2       55.0       46.4  
 
                             
Total Revenue
  $ 775.2     $ 762.2     $ 753.2     $ 744.0     $ 724.8  
 
                             
                                         
    As of  
    December 31,     September 30,     June 30,     March 31,     December 31,  
    2010     2010     2010     2010     2009  
12-Month Backlog
  $ 2,560     $ 2,525     $ 2,470     $ 2,460     $ 2,425